# KALM Therapeutics, Inc. — Form D

KALM Therapeutics, Inc. of HUNTSVILLE, AL, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-09. The offering totals $590K, of which $590K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-08-09
- Form: D
- Accession: 0002032945-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $590K
- Amount sold: $590K
- Minimum investment: $25K
- Investors: 14
- Date of first sale: 2024-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-521126

## Issuer

- Name: KALM Therapeutics, Inc.
- CIK: 0002032945
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 6820 MOQUIN DRIVE NW, HUNTSVILLE, AL, 35806
- Phone: (256) 715-9336

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Chris Seibert | Director | Huntsville, AL |
| Anuj Singhal | Director | Huntsville, AL |
| Chris Seibert | Executive Officer | Huntsville, AL |
| Anuj Singhal | Executive Officer | Huntsville, AL |

## More

- [CIK 2032945 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2032945&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002032945-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.